Tag: Health Care

Displaying 1 - 20 of 788 results.

Filtering by content type: Press Release

The settlement with TriVita, Inc. is part of the FTC’s ongoing efforts to stop over-hyped health claims.
Cosmetics company L’Oréal USA, Inc. has agreed to settle Federal Trade Commission charges of deceptive advertising about its Lancôme Génifique and L’Oréal Paris Youth Code skincare products. According to the FTC’s complaint, L’Oréal made false and unsubstantiated claims that its Génifique and...
FTC’s most recent fraud study shows that more consumers were victims of fraudulent weight-loss claims than of any other specific fraud type covered by the survey.
Supplement marketers i-Health, Inc. and Martek Biosciences Corporation have agreed to settle FTC charges of deceptive advertising for claiming that their BrainStrong Adult dietary supplement will improve adult memory and prevent cognitive decline.
The Federal Trade Commission has charged personal care company Lornamead, Inc. with deceiving consumers with exaggerated claims that its “Lice Shield” shampoo, stick, and spray products  will prevent or reduce the risk of getting head lice. Under an agreed-upon settlement, Lornamead will pay $500,...
The Federal Trade Commission has sued a Florida-based operation that capitalized on the green coffee diet fad by using bogus weight loss claims and fake news websites to market the dietary supplement Pure Green Coffee. Popularized on the syndicated talk show The Dr. Oz Show, green coffee bean...
Following a public comment period, the Federal Trade Commission has approved final consent orders settling charges that two marketers of genetically customized nutritional supplements deceptively advertised that their personalized nutritional supplements treat diabetes, heart disease, arthritis,...
Federal Trade Commission staff submitted written comments to Missouri State Representative Jeanne Kirkton in response to a request for comments on legislative proposals that would remove or change requirements for “collaborative practice arrangements” between Missouri physicians and Advanced...
The Federal Trade Commission announced the agenda and panelists for its upcoming seminar on the privacy ramifications of consumer generated and controlled health data, taking place on May 7 from 10 a.m. to noon in Washington, D.C.

Filtering by content type: Public Statement

Filtering by content type: Blog Post

It is a time of unprecedented change in the way health care services are provided and paid for in this country. As with other sectors of our economy that have experienced dramatic change, industry participants are reacting by developing new models, learning from their experiences, and adopting...

Filtering by content type: Case

Filtering by content type: Amicus Brief

Brief of the Federal Trade Commission as Amicus Curiae before the United States District Court for the Eastern District of Pennsylvania, addressing whether a branded company's commitment not to launch an authorized generic in competition with a generic company can constitute a...

Filtering by content type: Advocacy Filing

Filtering by content type: Closing Letter

Filtering by content type: Public Event

The Federal Trade Commission and the Antitrust Division of the Department of Justice held a one-day public workshop on June 23, 2014 to explore the economics and legal policy implications of certain pricing practices, such as loyalty and bundled pricing. The workshop, consisted of...

Filtering by content type: Report

Increased competition from the Internet has raised a concern of product quality for online prescription drugs. The Food and Drug Administration (FDA) prohibits the importation of unapproved drugs into the US and the National Association of Boards of Pharmacy (NABP) emphasizes their...

Pages